{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T04:31:30Z","timestamp":1648873890351},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Negat Results BioMed"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12952-014-0018-0","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T17:25:28Z","timestamp":1418318728000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of antibody to receptor activator of nuclear factor \u03ba-B ligand on inflammation and cartilage degradation in collagen antibody-induced arthritis in mice"],"prefix":"10.1186","volume":"13","author":[{"given":"Sakie","family":"Funato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koei","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Uyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Namiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunori","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryutaro","family":"Kamijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,12]]},"reference":[{"key":"18_CR1","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.2741\/1399","volume":"9","author":"C Ospelt","year":"2004","unstructured":"Ospelt C, Neidhart M, Gay RE, Gay S: Synovial activation in rheumatoid arthritis. Front Biosci. 2004, 9: 2323-2334. 10.2741\/1399.","journal-title":"Front Biosci"},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.0105-2896.2005.00327.x","volume":"208","author":"S Tanaka","year":"2005","unstructured":"Tanaka S, Nakamura K, Takahashi N, Suda T: Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol Rev. 2005, 208: 30-49. 10.1111\/j.0105-2896.2005.00327.x.","journal-title":"Immunol Rev"},{"key":"18_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/nm.2452","volume":"17","author":"T Nakashima","year":"2011","unstructured":"Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Fung JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, Penninger JM, Takayanagi H: Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011, 17: 1231-1234. 10.1038\/nm.2452.","journal-title":"Nat Med"},{"issue":"Suppl","key":"18_CR4","first-page":"ii1","volume":"42","author":"SR Goldring","year":"2003","unstructured":"Goldring SR: Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology. 2003, 42 (Suppl): ii1-ii16.","journal-title":"Rheumatology"},{"key":"18_CR5","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrrheum.2012.167","volume":"8","author":"H Takayanagi","year":"2012","unstructured":"Takayanagi H: New developments in osteoimmunology. Nat Rev Rheumatol. 2012, 8: 684-689. 10.1038\/nrrheum.2012.167.","journal-title":"Nat Rev Rheumatol"},{"key":"18_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutiluk S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christansen C, Freedom Trial: Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009, 361: 756-765. 10.1056\/NEJMoa0809493.","journal-title":"N Engl J Med"},{"key":"18_CR7","first-page":"331","volume":"7","author":"AJ Yee","year":"2012","unstructured":"Yee AJ, Raje NS: Denosumab, a RANK kigand inhibitor, for the management of bone loss in cancer patients. Clin Interv Aging. 2012, 7: 331-338.","journal-title":"Clin Interv Aging"},{"key":"18_CR8","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/art.23417","volume":"58","author":"SB Cohen","year":"2008","unstructured":"Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, van der Heijde D, Zhou L, Tsuji W, Newmark R: Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis. Arthritis Rheumat. 2008, 58: 1299-1309. 10.1002\/art.23417.","journal-title":"Arthritis Rheumat"},{"key":"18_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12020-012-9696-x","volume":"42","author":"K Sinningen","year":"2012","unstructured":"Sinningen K, Tsourdi E, Rauner M, Rachner TD, Hamann C, Hofbauer LC: Skeletal and extraskeletal actions of denosumab. Endocrine. 2012, 42: 52-62. 10.1007\/s12020-012-9696-x.","journal-title":"Endocrine"},{"key":"18_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1021\/bi992251u","volume":"39","author":"Z Li","year":"2000","unstructured":"Li Z, Hou W-S, Br\u00f6mme D: Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates. Biochemistry. 2000, 39: 529-536. 10.1021\/bi992251u.","journal-title":"Biochemistry"},{"key":"18_CR11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/art.10114","volume":"46","author":"W-S Hou","year":"2002","unstructured":"Hou W-S, Li W, Keyszer G, Weber E, Levy R, Klein MJ, Gravallese EM, Goldring SR, Br\u00f6mme D: Comparison of cathepsin K and S expression within the rheumatoid and osteoarthritic synovium. Arthritis Rheum. 2002, 46: 663-674. 10.1002\/art.10114.","journal-title":"Arthritis Rheum"},{"key":"18_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejphar.2009.03.074","volume":"613","author":"L Svelander","year":"2009","unstructured":"Svelander L, Erlandsson-Harris H, Astner L, Grabowska U, Klareskog L, Lindstrom E, Hewitt E: Inhibition of cathepsin K reduces bone erosion, cartilage degradation and inflammation evoked by collagen-induced arthritis in mice. Eur J Pharmacol. 2009, 613: 155-162. 10.1016\/j.ejphar.2009.03.074.","journal-title":"Eur J Pharmacol"},{"key":"18_CR13","doi-asserted-by":"publisher","first-page":"37023","DOI":"10.1074\/jbc.M111.246280","volume":"286","author":"Y Furuya","year":"2011","unstructured":"Furuya Y, Mori K, Ninomiya T, Tomimori Y, Yanaka S, Takahashi N, Udagawa N, Uchida K, Yasuda H: Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-kB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts. J Biol Chem. 2011, 286: 37023-37031. 10.1074\/jbc.M111.246280.","journal-title":"J Biol Chem"},{"key":"18_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1196\/annals.1443.016","volume":"1143","author":"A Leibbrandt","year":"2008","unstructured":"Leibbrandt A, Penninger JM: RANK\/RANKL: regulators of immune responses and bone physiology. Ann NY Acad Sci. 2008, 1143: 123-150. 10.1196\/annals.1443.016.","journal-title":"Ann NY Acad Sci"},{"key":"18_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998, 93: 165-176. 10.1016\/S0092-8674(00)81569-X.","journal-title":"Cell"},{"key":"18_CR16","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T: Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc Natl Acad Sci U S A. 1998, 95: 3597-3602. 10.1073\/pnas.95.7.3597.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18_CR17","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0002-9440(10)64417-3","volume":"161","author":"E Romas","year":"2002","unstructured":"Romas E, Sims NA, Hards DK, Lindsay M, Quinn JWM, Ryan PFJ, Dunstan CR, Martin J, Gillespie MT: Osteoprtegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. Am J Pathol. 2002, 161: 1419-1427. 10.1016\/S0002-9440(10)64417-3.","journal-title":"Am J Pathol"},{"key":"18_CR18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0002-9440(10)63144-6","volume":"164","author":"K Redlich","year":"2004","unstructured":"Redlich K, G\u00f6rtz B, Hayer S, Zwerina J, Doerr N, Kostenuik P, Bergmeister H, Kollias G, Steiner G, Snolen JS, Schett G: Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis. Am J Pathol. 2004, 164: 543-555. 10.1016\/S0002-9440(10)63144-6.","journal-title":"Am J Pathol"},{"key":"18_CR19","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/art.21021","volume":"52","author":"G Schett","year":"2005","unstructured":"Schett G, Middleton S, Bolon B, Stolina M, Brown H, Zhu L, Pretorius J, Zak DJ, Kostenuik P, Feige U: Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models. Arthritis Rheumat. 2005, 52: 1604-1611. 10.1002\/art.21021.","journal-title":"Arthritis Rheumat"},{"key":"18_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2879","volume":"11","author":"M Stolina","year":"2009","unstructured":"Stolina M, Schett G, Dwyer D, Vonderfecht S, Middleton S, Duryea D, Pacheco E, Van G, Bolon B, Feige U, Zack D, Kostenuil P: RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNF\u03b1 or anti-IL-1 therapies. Arthritis Res Ther. 2009, 11: 1-15. 10.1186\/ar2879.","journal-title":"Arthritis Res Ther"}],"container-title":["Journal of Negative Results in BioMedicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12952-014-0018-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12952-014-0018-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12952-014-0018-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12952-014-0018-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:47:05Z","timestamp":1630565225000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnrbm.biomedcentral.com\/articles\/10.1186\/s12952-014-0018-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["18"],"URL":"https:\/\/doi.org\/10.1186\/s12952-014-0018-0","relation":{},"ISSN":["1477-5751"],"issn-type":[{"value":"1477-5751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"30 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"18"}}